BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

756 related articles for article (PubMed ID: 29270239)

  • 1. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
    Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
    Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Gonzaga IM; Soares Lima SC; Nicolau MC; Nicolau-Neto P; da Costa NM; de Almeida Simão T; Hernandez-Vargas H; Herceg Z; Ribeiro Pinto LF
    Clin Epigenetics; 2017; 9():130. PubMed ID: 29296124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients.
    Kuo IY; Chang JM; Jiang SS; Chen CH; Chang IS; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
    Int J Med Sci; 2014; 11(8):779-87. PubMed ID: 24936140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a DNA methylome profile of esophageal squamous cell carcinoma and potential plasma epigenetic biomarkers for early diagnosis.
    Li X; Zhou F; Jiang C; Wang Y; Lu Y; Yang F; Wang N; Yang H; Zheng Y; Zhang J
    PLoS One; 2014; 9(7):e103162. PubMed ID: 25050929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter methylation in cytology specimens as an early detection marker for esophageal squamous dysplasia and early esophageal squamous cell carcinoma.
    Adams L; Roth MJ; Abnet CC; Dawsey SP; Qiao YL; Wang GQ; Wei WQ; Lu N; Dawsey SM; Woodson K
    Cancer Prev Res (Phila); 2008 Oct; 1(5):357-61. PubMed ID: 19137073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Hyper-Methylated Tumor Suppressor Genes-Based Diagnostic Panel for Esophageal Squamous Cell Carcinoma (ESCC) in a Chinese Han Population.
    Wang C; Pu W; Zhao D; Zhou Y; Lu T; Chen S; He Z; Feng X; Wang Y; Li C; Li S; Jin L; Guo S; Wang J; Wang M
    Front Genet; 2018; 9():356. PubMed ID: 30233644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma.
    Nagata H; Kozaki KI; Muramatsu T; Hiramoto H; Tanimoto K; Fujiwara N; Imoto S; Ichikawa D; Otsuji E; Miyano S; Kawano T; Inazawa J
    Oncotarget; 2017 Jun; 8(23):37740-37750. PubMed ID: 28465481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide profiling of DNA methylation and gene expression in esophageal squamous cell carcinoma.
    Chen C; Peng H; Huang X; Zhao M; Li Z; Yin N; Wang X; Yu F; Yin B; Yuan Y; Lu Q
    Oncotarget; 2016 Jan; 7(4):4507-21. PubMed ID: 26683359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A six-CpG panel with DNA methylation biomarkers predicting treatment response of chemoradiation in esophageal squamous cell carcinoma.
    Chang WL; Lai WW; Kuo IY; Lin CY; Lu PJ; Sheu BS; Wang YC
    J Gastroenterol; 2017 Jun; 52(6):705-714. PubMed ID: 27671002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.
    Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.
    Guo W; Dong Z; Cui J; Guo Y; Shen S; Guo X; Kuang G
    Clin Exp Metastasis; 2016 Jan; 33(1):73-85. PubMed ID: 26482475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic changes within the promoter regions of antigen processing machinery family genes in Kazakh primary esophageal squamous cell carcinoma.
    Sheyhidin I; Hasim A; Zheng F; Ma H
    Asian Pac J Cancer Prev; 2014; 15(23):10299-306. PubMed ID: 25556465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.
    He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S
    Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA Methylation Status of PAX1 and ZNF582 in Esophageal Squamous Cell Carcinoma.
    Huang J; Wang G; Tang J; Zhuang W; Wang LP; Liou YL; Liu YZ; Zhou HH; Zhu YS
    Int J Environ Res Public Health; 2017 Feb; 14(2):. PubMed ID: 28241446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
    Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
    Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a DNA methylome signature of esophageal squamous cell carcinoma and potential epigenetic biomarkers.
    Lima SC; Hernández-Vargas H; Simão T; Durand G; Kruel CD; Le Calvez-Kelm F; Ribeiro Pinto LF; Herceg Z
    Epigenetics; 2011 Oct; 6(10):1217-27. PubMed ID: 21946330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG location and methylation level are crucial factors for the early detection of oral squamous cell carcinoma in brushing samples using bisulfite sequencing of a 13-gene panel.
    Morandi L; Gissi D; Tarsitano A; Asioli S; Gabusi A; Marchetti C; Montebugnoli L; Foschini MP
    Clin Epigenetics; 2017; 9():85. PubMed ID: 28814981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulated promoter methylation as a potential biomarker for esophageal cancer.
    Peng X; Xue H; Lü L; Shi P; Wang J; Wang J
    Oncotarget; 2017 Jan; 8(1):679-691. PubMed ID: 27893424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network-based analysis identifies epigenetic biomarkers of esophageal squamous cell carcinoma progression.
    Cheng CP; Kuo IY; Alakus H; Frazer KA; Harismendy O; Wang YC; Tseng VS
    Bioinformatics; 2014 Nov; 30(21):3054-61. PubMed ID: 25015989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LMP gene promoter hypermethylation is a mechanism for its down regulation in Kazak's esophageal squamous cell carcinomas.
    Zheng F; Hasim A; Anwer J; Niyaz M; Sheyhidin I
    Mol Biol Rep; 2013 Mar; 40(3):2069-75. PubMed ID: 23283737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.